在卵巢和子宫内膜癌症中,计算洞察力对伊利诺特干与UBE2I的相互作用
Tamizhini Loganathan1, Madhulekha S1, Hatem Zayed2
1Laboratory of Integrative Genomics, Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India.
Computational biology and chemistry
|October 30, 2024
概括
这项研究揭示了子宫内膜和卵巢癌中常见的分子通路,突出了细胞周期和DNA损伤检查点. UBE2I被确定为一种潜在的生物标志物,而 irinotcan 化物显示出治疗前景.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 子宫内膜癌 (EC) 和卵巢癌 (OC) 是普遍存在的,致命的生殖疾病预后不佳.
- 在OC中雌激素水平升高可以刺激子宫内膜,可能导致EC,但它们的共同致病性仍然不清楚.
研究的目的:
- 在EC和OC中确定共同的分子通路和差异表达基因 (DEGs).
- 探索这些癌症的潜在生物标志物和治疗点.
主要方法:
- 利用生物信息学工具分析EC和OC的多个基因表达微阵列数据集.
- 进行了差异基因表达分析,功能关联研究和分子对接/动力学模拟.
主要成果:
- 在两种癌症中确定了与DNA损伤,DNA完整性和细胞周期检查点信号通路相关的关键DEG.
- 发现了10个常见的枢纽基因 (CLDN7,UBE2I,WT1,JAM2,FOXL2,F11R,JAM3,ZFPM2,MEF2C,PIAS1),其中CLDN7和F11R是上调的,而其他基因是下调的.
- 分子对接和动力学表明UBE2I蛋白质是氨酸氨酸的潜在治疗标.
结论:
- 这项研究揭示了一个共同的分子框架,涉及CE和OC病原体的细胞周期和DNA损伤/完整性检查点.
- 建议UBE2I作为EC和OC的潜在生物标志物.
- 氨酸氨酸表明对UBE2I的潜在治疗疗效,这表明一种新的治疗方法.
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


